XML 78 R4.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2015
Dec. 31, 2014
Current Assets    
Cash and cash equivalents (variable interest entity restricted - 2015: $1; 2014: $1) $ 988 $ 780
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2015: $6; 2014: $9) 873 801
Non-trade receivables, net 226 241
Inventories 762 782
Deferred income taxes 15 29
Marketable securities, at fair value 29 32
Other assets 30 33
Total current assets 2,923 2,698
Investments in affiliates 821 876
Property, plant and equipment (net of accumulated depreciation - 2015: $1,930; 2014: $1,816; variable interest entity restricted - 2015: $716; 2014: $535) 3,771 3,733
Deferred income taxes 260 253
Other assets (variable interest entity restricted - 2015: $38; 2014: $24) 372 377
Goodwill 716 749
Intangible assets (net of accumulated amortization - 2015: $533; 2014: $556) 125 132
Total assets 8,988 8,818
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 123 137
Trade payables - third party and affiliates 736 757
Other liabilities 298 432
Deferred income taxes 6 7
Income taxes payable 105 5
Total current liabilities 1,268 1,338
Long-term debt 2,552 2,608
Deferred income taxes 127 141
Uncertain tax positions 164 159
Benefit obligations 1,130 1,211
Other liabilities $ 262 $ 283
Commitments and Contingencies    
Stockholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2015 and 2014: 0 issued and outstanding) $ 0 $ 0
Treasury stock, at cost (2015: 13,275,889 shares; 2014: 13,266,625 shares) (611) (611)
Additional paid-in capital 120 103
Retained earnings 3,848 3,491
Accumulated other comprehensive income (loss), net (281) (165)
Total Celanese Corporation stockholders' equity 3,076 2,818
Noncontrolling interests 409 260
Total equity 3,485 3,078
Total liabilities and equity 8,988 8,818
Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2015: 166,619,120 issued and 153,343,231 outstanding; 2014: 166,169,335 issued and 152,902,710 outstanding)    
Stockholders' Equity    
Common stock 0 0
Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2015 and 2014: 0 issued and outstanding)    
Stockholders' Equity    
Common stock $ 0 $ 0